Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Pathogens (Basel, Switzerland)|October 29, 2025
A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal DiseaseJulio Ramirez, Stephen Furmanek, Thomas Chandler, et al.
Vaccine|January 3, 2012
Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidisAngela Martino, Claudia Magagnoli, Giuseppe De Conciliis, et al.
The New England Journal of Medicine|July 29, 2016
Immunogenicity of a Meningococcal B Vaccine during a University OutbreakNicole E Basta, Adel A F Mahmoud, Julian Wolfson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancyJamie Findlow, Ray Borrow, Matthew D Snape, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2009
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesAndrew R Gorringe, Stephen Taylor, Charlotte Brookes, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trialMatthew D Snape, Tom Dawson, Philipp Oster, et al.
Msphere|August 24, 2018
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <i>Neisseria meningitidis</i> Isolated from 2009 to 2013 in the Republic of IrelandRobert M Mulhall, Desiree Bennett, Robert Cunney, et al.
Infectious Diseases and Therapy|January 30, 2025
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix<sup>®</sup> Vaccine When Given to Healthy Infants at 3 and 12 Months of AgeSusanna Koski, Federico Martinon-Torres, Mika Rämet, et al.
Journal of Clinical Microbiology|September 18, 2009
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and WalesJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Infection and Immunity|July 25, 2006
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvacJamie Findlow, Stephen Taylor, Audun Aase, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Pathogens (Basel, Switzerland)|October 29, 2025
A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal DiseaseJulio Ramirez, Stephen Furmanek, Thomas Chandler, et al.
Vaccine|January 3, 2012
Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidisAngela Martino, Claudia Magagnoli, Giuseppe De Conciliis, et al.
The New England Journal of Medicine|July 29, 2016
Immunogenicity of a Meningococcal B Vaccine during a University OutbreakNicole E Basta, Adel A F Mahmoud, Julian Wolfson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancyJamie Findlow, Ray Borrow, Matthew D Snape, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2009
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesAndrew R Gorringe, Stephen Taylor, Charlotte Brookes, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trialMatthew D Snape, Tom Dawson, Philipp Oster, et al.
Msphere|August 24, 2018
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <i>Neisseria meningitidis</i> Isolated from 2009 to 2013 in the Republic of IrelandRobert M Mulhall, Desiree Bennett, Robert Cunney, et al.
Infectious Diseases and Therapy|January 30, 2025
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix<sup>®</sup> Vaccine When Given to Healthy Infants at 3 and 12 Months of AgeSusanna Koski, Federico Martinon-Torres, Mika Rämet, et al.
Journal of Clinical Microbiology|September 18, 2009
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and WalesJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Infection and Immunity|July 25, 2006
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvacJamie Findlow, Stephen Taylor, Audun Aase, et al.
Pageof 10